Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.

[1]  H. Terai,et al.  A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. , 2004, Biochemical and biophysical research communications.

[2]  Toshitaka Nakamura,et al.  Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. , 2004, Bone.

[3]  K. Takaoka,et al.  Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. , 2003, Biomaterials.

[4]  K. Takaoka,et al.  Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. , 2003, Bone.

[5]  P. Aspenberg,et al.  Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Noninstrumented Posterolateral Lumbar Fusion: 2002 Volvo Award in Clinical Studies , 2002, Spine.

[6]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[7]  K. Takaoka,et al.  Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer. , 2002, Journal of biomedical materials research.

[8]  C. Dickman,et al.  Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.

[9]  H. Herschman,et al.  Bone Morphogenetic Protein 2 Induces Cyclo‐oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo , 2002 .

[10]  E. Schwarz,et al.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. , 2002, The Journal of clinical investigation.

[11]  R. Breyer,et al.  Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. , 2002, Bone.

[12]  K. Takaoka,et al.  Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2. , 2002, Bone.

[13]  S. Narumiya,et al.  Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Leu,et al.  Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). , 2001, Molecular pharmacology.

[15]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[16]  Kazutoshi Nozaki,et al.  A biodegradable polymer as a cytokine delivery system for inducing bone formation , 2001, Nature Biotechnology.

[17]  K. Takaoka,et al.  Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. , 2000, Bone.

[18]  S. Narumiya,et al.  Impaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice* , 2000, The Journal of Biological Chemistry.

[19]  S. Narumiya,et al.  The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. , 2000, Endocrinology.

[20]  K. Nakao,et al.  Crucial Involvement of the EP4 Subtype of Prostaglandin E Receptor in Osteoclast Formation by Proinflammatory Cytokines and Lipopolysaccharide , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Boden,et al.  The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.

[22]  S. Narumiya,et al.  Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Weinreb,et al.  The anabolic effect of PGE2in rat bone marrow cultures is mediated via the EP4 receptor subtype. , 1999, American journal of physiology. Endocrinology and metabolism.

[24]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[25]  Atsushi Ichikawa,et al.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 , 1998, Nature.

[26]  S. Narumiya,et al.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. , 1998, Biochemical and biophysical research communications.

[27]  S. Narumiya,et al.  Prostaglandin E receptor subtypes in mouse osteoblastic cell line. , 1996, Endocrinology.

[28]  H. Kawaguchi,et al.  The role of prostaglandins in the regulation of bone metabolism. , 1995, Clinical orthopaedics and related research.

[29]  A. Schoutens,et al.  Prostaglandins and bone. , 1995, Bone.

[30]  S. Narumiya,et al.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. , 1994, Pharmacological reviews.

[31]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[32]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[33]  K. Sone,et al.  Long-term low-dose prostaglandin E1 administration. , 1980, The Journal of pediatrics.

[34]  B. Kream,et al.  Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin. , 1979, Prostaglandins.

[35]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[36]  D. Woodbury,et al.  The effects of prostaglandin E2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formation , 2007, Calcified Tissue International.

[37]  S. Keila,et al.  A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. , 2004, Bone.

[38]  Rong-Sen Yang,et al.  Increased bone growth by local prostaglandin E2 in rats , 2004, Calcified Tissue International.

[39]  R. A. Coleman,et al.  New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.